Hepatitis B Clinical Trial
— LHWAAOfficial title:
Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans
Verified date | May 2016 |
Source | Thomas Jefferson University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The study was conducted between April 2013 and October 2014. In the parent study, 600
foreign-born Asian American adults 18 years of age and older were drawn from the community
in the Baltimore Washington Metropolitan Area. Using a non-probability sampling method,
foreign-born Asian American adults, 18 years of age and older, were recruited from the
community.
After providing informed consent, all the participants were asked to complete a
self-administered questionnaire in English, Chinese, Korean, or Vietnamese with the
assistance of a bilingual interviewer when necessary. Then, all of the participants were
instructed and given 5 to 10 to minutes to read culturally integrated and linguistically
appropriate educational material (e.g., Photo novel) developed and validated for efficacy
from a prior study.
All participants received hepatitis B testing: HBsAg (hepatitis B surface antigen), HBsAb
(hepatitis B surface antibody) and, HBcAb (hepatitis B core antibody). A total of 600
completed the survey and screening. A week later, they received the results of the screening
test. Based on the screening results, all participants were categorized into three groups:
(1) infected (HbsAg+), (2) unprotected (HbsAg-/HbsAb-), or (3) protected (HbsAg-/HbsAb+). We
sent the results by mail to participants who were unprotected and protected. Among those 600
screened participants, 33(5.5%) had chronic hepatitis B virus (HBV) infection and 335
(55.8%) had evidence of resolved HBV infection (protected). A total of 232 (38.7%) were
susceptible to HBV infection (unprotected).
LHW (lay health worker) Intervention for those unprotected: Those unprotected (n=232) were
randomly assigned to either the intervention (n=124) or the control (n=108) groups by
computer-automated random assignment. Randomization was used to assure equivalence between
groups on key factors that may potentially influence the outcome of HBV vaccinations:
gender, age, education, length of stay in the U.S.
LHWs conducted phone interventions by reminding participants of a series of vaccinations at
months 1, 2, and 5 among those assigned to the intervention group. Those in the control
group received a list of resources along with their results by mail that offered free
vaccinations, such as local health departments. Seven months after mailing the results,
those unprotected were followed up by phone to ask about their status of the series of
vaccinations and about promoters or barriers to vaccinations.
Status | Completed |
Enrollment | 232 |
Est. completion date | October 2014 |
Est. primary completion date | October 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - foreign-born Asian American adults - 18 years of age and older - unprotected (HbsAg-/HbsAb-) Exclusion Criteria: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Thomas Jefferson University | National Cancer Institute (NCI) |
Anderson GF, Hussey PS. Population aging: a comparison among industrialized countries. Health Aff (Millwood). 2000 May-Jun;19(3):191-203. — View Citation
Caulfield LE, Gross SM, Bentley ME, Bronner Y, Kessler L, Jensen J, Weathers B, Paige DM. WIC-based interventions to promote breastfeeding among African-American Women in Baltimore: effects on breastfeeding initiation and continuation. J Hum Lact. 1998 Mar;14(1):15-22. — View Citation
Earp JA, Viadro CI, Vincus AA, Altpeter M, Flax V, Mayne L, Eng E. Lay health advisors: a strategy for getting the word out about breast cancer. Health Educ Behav. 1997 Aug;24(4):432-51. — View Citation
Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001 Aug;44(2):119-27. Review. — View Citation
Han HR, Lee H, Kim MT, Kim KB. Tailored lay health worker intervention improves breast cancer screening outcomes in non-adherent Korean-American women. Health Educ Res. 2009 Apr;24(2):318-29. doi: 10.1093/her/cyn021. Epub 2008 May 7. — View Citation
Hsu CE, Liu LC, Juon HS, Chiu YW, Bawa J, Tillman U, Li M, Miller J, Wang M. Reducing liver cancer disparities: a community-based hepatitis-B prevention program for Asian-American communities. J Natl Med Assoc. 2007 Aug;99(8):900-7. — View Citation
Juon HS, Strong C, Oh TH, Castillo T, Tsai G, Oh LD. Public health model for prevention of liver cancer among Asian Americans. J Community Health. 2008 Aug;33(4):199-205. doi: 10.1007/s10900-008-9091-y. — View Citation
Lefebvre RC, Flora JA. Social marketing and public health intervention. Health Educ Q. 1988 Fall;15(3):299-315. Review. — View Citation
Saunders RP, Evans MH, Joshi P. Developing a process-evaluation plan for assessing health promotion program implementation: a how-to guide. Health Promot Pract. 2005 Apr;6(2):134-47. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | self-reported status of the series of HBV vaccinations by follow-up calls in seven months after mailing the results verified by the medical records | Seven months after mailing the results, those unprotected were followed up by phone to ask about their status of the series of vaccinations and about promoters or barriers to vaccinations. Their self-reported vaccinations were verified with the medical records. Participants were asked to provide information about the date of vaccinations as well as the location of the clinic or doctor's office where participants received vaccinations. Participants were also asked to sign a medical release form giving project staff permission to request medical records regarding their vaccinations. Each participant was given a stamped vaccination card to fill out the date and provide the signature of their physician following each completed hepatitis B vaccination. Participants were asked to mail the card back to the research team once the card was completed. | Seven months after mailing the results | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01182311 -
Duration of Long-term Immunity After Hepatitis B Virus Immunization
|
||
Completed |
NCT04971928 -
Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment
|
Phase 1 | |
Completed |
NCT03285620 -
A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants
|
Phase 1 | |
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
Completed |
NCT02153320 -
Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT00352963 -
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).
|
Phase 3 | |
Completed |
NCT03567382 -
Arresting Vertical Transmission of Hepatitis B Virus
|
Phase 4 | |
Not yet recruiting |
NCT04056728 -
A Phase IV Study to Assess the Safety of EupentaTM Inj
|
Phase 4 | |
Not yet recruiting |
NCT03604016 -
Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
|
Phase 4 | |
Completed |
NCT00753649 -
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
|
Phase 4 | |
Recruiting |
NCT03027258 -
Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome
|
N/A | |
Completed |
NCT02540538 -
Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders
|
Phase 1 | |
Terminated |
NCT02604199 -
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
|
Phase 2 | |
Completed |
NCT02421666 -
A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV
|
N/A | |
Completed |
NCT02169674 -
Hepatitis B Booster Study in Adolescence
|
Phase 4 | |
Completed |
NCT01917357 -
A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject
|
Phase 3 | |
Completed |
NCT01368497 -
Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
|
Phase 3 | |
Completed |
NCT01732354 -
Study for Consolidation Period of Chronic Hepatitis B
|
||
Recruiting |
NCT01462981 -
Cohort of Hepatitis B Research of Amsterdam
|
N/A |